Efficacy and Safety of Budesonide Orodispersible Tablets for Eosinophilic Esophagitis up to 3 Years: an Open-Label Extension Study.
Biedermann L, Schlag C, Straumann A, Lucendo AJ, Miehlke S, Vieth M, Santander C, Ciriza de Los Rios C, Schmöcker C, Madisch A, Hruz P, Hayat J, von Arnim U, Bredenoord AJ, Schubert S, Halstead M, Pfurr S, Mueller R, Schoepfer AM, Attwood S; International EOS-2 Study Group.
Biedermann L, et al. Among authors: hayat j.
Clin Gastroenterol Hepatol. 2024 Dec 16:S1542-3565(24)01088-7. doi: 10.1016/j.cgh.2024.10.034. Online ahead of print.
Clin Gastroenterol Hepatol. 2024.
PMID: 39694205
Free article.